Angiopoietin-1 and Myeloma-Induced Angiogenesis
- 1 January 2005
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 46 (1) , 29-33
- https://doi.org/10.1080/1042-8190400001022
Abstract
Multiple myeloma (MM) is a plasma cell malignancy characterized by an increase of the bone marrow angiogenesis. Angiopoietin-1 (Ang-1) is a critical factor in the regulation of physiological and pathological vessel formation that acts by binding to a specific receptor Tie2 expressed on endothelial cells. Recent evidences indicate that human MM cells produce Ang-1 and up-regulate its receptor Tie2 in bone marrow endothelial cells. An overexpression of Ang-1 has been also found in MM cells as compared to normal plasma cells. The correlation between Ang-1 expression and BM angiogenesis, demonstrated in MM patients, and the inhibitory effect of Tie2 blocking on MM-induced vessel formation suggest that Ang-1 production by MM cells is critically involved in the angiogenic process in MM. In this review we focalize our attention on Ang-1/Tie2 system and its role in MM-induced angiogenesis.Keywords
This publication has 41 references indexed in Scilit:
- Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesisLeukemia, 2004
- Do human myeloma cells directly produce basic FGF?Blood, 2003
- Angiopoietins in angiogenesis and beyondExpert Opinion on Investigational Drugs, 2003
- Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myelomaBlood, 2003
- Bone marrow angiogenesis in patients with active multiple myelomaSeminars in Oncology, 2001
- Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosisSeminars in Oncology, 2001
- Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignanciesSeminars in Oncology, 2001
- Angiogenesis in cancer and other diseasesNature, 2000
- New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGFOncogene, 1999
- Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression CloningCell, 1996